Solid Biosciences director exercises 3,441 RSUs
Solid Biosciences Inc. director Ian F. Smith exercised restricted stock units into common shares.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Solid Biosciences Inc. director Ian F. Smith exercised restricted stock units into common shares. On April 2, 2026 he converted 3,441 restricted stock units into 3,441 shares of common stock at a stated price of $0.00 per share.
The restricted stock units were granted on January 2, 2026 and vest in equal quarterly installments over 12 months from the grant date. Following this transaction, Smith holds 134,705 shares of common stock directly and 10,320 restricted stock units.
Insider Trade Summary
3,441 shares exercised/converted
Exercise
2 txns
Insider
SMITH IAN F
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 3,441 | $0.00 | $0.00 |
| Exercise | Common Stock | 3,441 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 10,320 contracts (Direct);
Common Stock — 134,705 shares (Direct)
Footnotes (2)
- F1. Restricted stock units convert to common stock on a one-for-one basis.
- F2. The restricted stock units were granted on January 2, 2026 and vested in equal quarterly installments beginning three months from the date of grant, with the final installment vesting 12 months from the date of grant.
Key Figures
RSUs exercised: 3,441 units
Common shares acquired: 3,441 shares
Common shares after transaction: 134,705 shares
+2 more
5 metrics
RSUs exercised
3,441 units
Restricted stock units converted to common stock on April 2, 2026
Common shares acquired
3,441 shares
Common stock received from RSU conversion on April 2, 2026
Common shares after transaction
134,705 shares
Direct holdings of Ian F. Smith following the RSU conversion
RSUs remaining
10,320 units
Restricted stock units held after the reported Form 4 transactions
RSU grant date
January 2, 2026
Grant date for restricted stock units vesting in equal quarterly installments
Key Terms
Restricted Stock Units, derivative security, exercise or conversion, vesting
4 terms
Restricted Stock Units financial
"Restricted stock units convert to common stock on a one-for-one basis."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
derivative security financial
"Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
exercise or conversion financial
"transaction_action: derivative exercise/conversion"
vesting financial
"vested in equal quarterly installments beginning three months from the date of grant"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Solid Biosciences (SLDB) report for Ian F. Smith?
Ian F. Smith exercised 3,441 restricted stock units into 3,441 common shares. The units converted on April 2, 2026 at a stated price of $0.00 per share, reflecting a routine equity compensation vesting event for a company director.
What are the terms of the restricted stock units in this Solid Biosciences (SLDB) filing?
The restricted stock units convert to common stock on a one-for-one basis. They were granted on January 2, 2026 and vest in equal quarterly installments over 12 months, beginning three months from the grant date, providing staged equity compensation.
Was the Solid Biosciences (SLDB) insider transaction a purchase or an option exercise?
The transaction was an exercise or conversion of a derivative security, not an open-market purchase. Restricted stock units were converted into common shares at a stated price of $0.00, reflecting equity compensation vesting rather than a cash stock purchase.
How many restricted stock units does Ian F. Smith retain in Solid Biosciences (SLDB)?
Following the reported transaction, Ian F. Smith holds 10,320 restricted stock units. These units represent additional potential common shares subject to vesting terms described in the grant, which call for equal quarterly vesting over a 12-month period from January 2, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
